The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFα

Regulatory Peptides

Volumn 157, Issue 1-3, 2009, Pages 57-63

  Kunnari, Anne M ^a   Savolainen, Eeva Riitta ^a   Ukkola, Olavi H ^a   Kesäniemi, Y Antero ^a   Jokela, Maarit A ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Adhesion molecule; Endothelial cell; Lymphocyte; Macrophage; Monocyte; Neutrophil

Indexed keywords

CD31 ANTIGEN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; INFLAMMATORY DISEASE; LEUKEMIA CELL LINE; LEUKOCYTE; MACROPHAGE; MONOCYTE; MYELOBLAST; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; T LYMPHOCYTE; UPREGULATION;

CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HL-60 CELLS; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; RESISTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68449104754     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.05.002     Document Type: Article

References (33)

1. Vanderlaan P.A., and Reardon C.A. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 46 (2005) 829-838
2. Burnett M.S., Lee C.W., Kinnaird T.D., Stabile E., Durrani S., Dullum M.K., et al. The potential role of resistin in atherogenesis. Atherosclerosis 182 (2005) 241-248
3. Jung H.S., Park K., Cho Y.M., Chung S.S., Cho H.J., Cho S.Y., et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69 (2006) 76-85
4. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 314 (2004) 415-419
5. Skilton M.R., Nakhla S., Sieveking D.P., Caterson I.D., and Celermajer D.S. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32 (2005) 839-844
6. Verma S., Li S., Wang C., Fedak P.W.M., Li R., Weisel R.D., et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108 (2003) 736-740
7. Calabro P., Samudio I., Willerson J.T., and Yeh E.T.H. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110 (2004) 3335-3340
8. Migita K., Maeda Y., Miyashita T., Kimura H., Nakamura M., Ishibashi H., et al. The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol 24 (2006) 698-701
9. Bokarewa M., Nagaev I., Dahlberg L., Smith U., and Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 174 (2005) 5789-5795
10. Senolt L., Housa D., Vernerová Z., Jirásek T., Svobodová R., Veigl D., et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 66 (2007) 458-463
11. Schäffler A., Ehling A., Neumann E., Herfarth H., Tarner I., Schölmerich J., et al. Adipocytokines in synovial fluid. JAMA 290 (2003) 1709-1710
12. Konrad A., Lehrke M., Schachinger V., Seibold F., Stark R., Ochsenkühn T., et al. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol 19 (2007) 1070-1074
13. Larochelle J., Freiler J., Dice J., and Hagan L. Plasma resistin levels in asthmatics as a marker of disease state. J Asthma 44 (2007) 509-513
14. Stejskal D., Adamovská S., Bartek J., Juráková R., and Prosková J. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147 (2003) 63-69
15. Sundén-Cullberg J., Nyström T., Lee M.L., Mullins G.E., Tokics L., Andersson J., et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med 35 (2007) 1536-1542
16. Yang R., Huang Q., Xu A., McLenithan J.C., Eisen J.A., Shuldiner A.R., et al. Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 310 (2003) 927-935
17. Savage D.B., Sewter C.P., Klenk E.S., Segal D.G., Vidal-Puig A., Considine R.V., et al. Resistin/FIZZ3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50 (2001) 2199-2202
18. Patel L., Buckels A.C., Kinghorn I.J., Murdock P.R., Holbrook J.D., Plumpton C., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300 (2003) 472-476
19. Lehrke M., Reilly M.P., Millington S.C., Iqbal N., Rader D.J., and Lazar M.A. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1 (2004) e45
20. Nagaev I., Bokarewa M., Tarkowski A., and Smith U. Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE 1 (2006) e31
21. Chumakov A.M., Kubota T., Walter S., and Koeffler H.P. Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/resistin gene family. Oncogene 23 (2004) 3414-3425
22. Schinke T., Haberland M., Jamshidi A., Nollau P., Rueger J.M., and Amling M. Cloning and functional characterization of resistin-like molecule gamma. Biochem Biophys Res Commun 314 (2004) 356-362
23. Anderson P.D., Mehta N.N., Wolfe M.L., Hinkle C.C., Pruscino L., Comiskey L.L., et al. Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 92 (2007) 2272-2279
24. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., and Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309 (2003) 286-290
25. Lu S., Shieh W., Chen C., Hsu S., and Chen H. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530 (2002) 158-162
26. Kunnari A., Ukkola O., Päivänsalo M., and Kesäniemi Y.A. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 91 (2006) 2755-2760
27. Akeson A.L., and Woods C.W. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods 163 (1993) 181-185
28. Xu W., Yu L., Zhou W., and Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem Biophys Res Commun 351 (2006) 376-382
29. Fleck R.A., Romero-Steiner S., and Nahm M.H. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clin Diagn Lab Immunol 12 (2005) 19-27
30. Dwivedi A., Anggård E.E., and Carrier M.J. Oxidized LDL-mediated monocyte adhesion to endothelial cells does not involve NFkappab. Biochem Biophys Res Commun 284 (2001) 239-244
31. Nübel T., Dippold W., Kleinert H., Kaina B., and Fritz G. Lovastatin inhibits rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. FASEB J 18 (2004) 140-142
32. Appelberg R. Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol 15 (2007) 87-92
33. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., and Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol Rev 177 (2000) 195-203